Analysis of the efficacy of the da Vinci robot in surgery for posterior mediastinal neurogenic tumors

Abstract

Background The present research is designed to evaluate the short-term outcome of robot-assisted thoracoscopic surgery (RATS) for the treatment of posterior mediastinal neurogenic tumors. Methods We retrospectively analyzed clinical data on 39 consecutive patients with mediastinal neurogenic tumors after RATS treatment completed by the same operator in the Department of Thoracic Surgery, Gansu Provincial People's Hospital from January 2016 to September 2022. There were 22 males and 17 females with a mean age of (35.1 ± 6.9) years in this analysis report. The tumors of the patients were localized and evaluated preoperatively using magnetic resonance imaging (MRI) or enhanced CT. Results All 39 patients successfully underwent the resection of posterior mediastinal neurogenic tumors under RATS, and no conversion to thoracotomy occurred during the operations. The average operative time was (62.1 ± 17.2) min, the average docking time was (10.1 ± 2.5) min, the average intraoperative bleeding was (32.8 ± 19.5) ml, the average 24-h postoperative chest drainage was (67.4 ± 27.9) ml, the average postoperative chest drainage time was (2.2 ± 1.3) days and the average post-operative hospital stay was (3.2 ± 1.3) days. Postoperative complications occurred in 3 patients, including 2 patients with transient Horner's syndrome after surgery and 1 patient with transient anhidrosis of the affected upper limb after surgery. Conclusion RATS for posterior mediastinal neurogenic tumors is safe, effective, feasible and bring the superiority of robotic surgical system into full play.

Efficacy of using Maryland forceps versus electrocoagulation hooks in da Vinci robot-assisted thoracoscopic mediastinal tumor resection

“…2 Department of thoracic surgery, Gansu Provincial Hospital, Lanzhou, China. 3 Lanzhou First People's Hospital, Lanzhou, China.…”

“…When the tumors gradually increase in size, they may produce compression symptoms on the surrounding tissues and organs, and are often treated clinically by surgery [1,2]. With the continuous development of minimally invasive technology, the minimally invasive surgical operation system represented by robot-assisted thoracic surgery (RATS) has been widely used in mediastinal tumor resection [3][4][5]. Two most commonly used energy instruments in current robotic surgical systems are EH and MF.…”

Efficacy of the da Vinci robot versus thoracoscopic surgery for patients with mediastinal tumors of different body mass index: a multicenter propensity score-matched study

“…Several studies have demonstrated that video-assisted thoracoscopic surgery (VATS) has signi cant advantages over conventional surgery, including shorter postoperative hospital stay, fewer complications, and lesser pain, and has now became a major surgical modality in thoracic surgery [2,3]. However, VATS has some inherent shortcomings, such as a two-dimensional eld of view, inadequate handling in a con ned space (especially for upper mediastinal and parietal pleural lesions), and more di cult operations such as suturing and knotting [4]. Given the above-mentioned shortcomings of thoracoscopy, robotic-assisted surgical systems emerged and have been widely employed in thoracic surgery in recent decades.…”

A comparative study of robotic surgery and thoracoscopic surgery for mediastinal cysts

“…With the rapid development of surgical instruments, RATS has been used increasingly in clinical applications. Compared with VATS, RATS has been widely used for esophagectomy, lobectomy, and other thoracic surgeries due to its advantages in automatic tremor ltering, three-dimensional eld of view, 10-fold magni ed images, and 7 degrees of freedom of rotation [3][4][5], whereas scarce investigations on RATS for resection of mediastinal cysts have been reported. This study retrospectively analyzed the clinical data of 70 cases of minimally invasive surgery for mediastinal cysts completed at our center from April 2014 to December 2022, including 37 cases in the RATS group and 38 cases in the VATS group, to evaluate the safety and e cacy of RATS.…”